These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 27799168)

  • 1. Fibrinogen-is it a universal haemostatic agent?
    Bolliger D; Tanaka KA
    Br J Anaesth; 2016 Nov; 117(5):548-550. PubMed ID: 27799168
    [No Abstract]   [Full Text] [Related]  

  • 2. For: Fibrinogen concentrate for management of bleeding.
    Rahe-Meyer N; Sørensen B
    J Thromb Haemost; 2011 Jan; 9(1):1-5. PubMed ID: 20946151
    [No Abstract]   [Full Text] [Related]  

  • 3. Against: Fibrinogen concentrate for management of bleeding: against indiscriminate use.
    Ozier Y; Hunt BJ
    J Thromb Haemost; 2011 Jan; 9(1):6-8. PubMed ID: 21210948
    [No Abstract]   [Full Text] [Related]  

  • 4. From life-blood streaming to hemostasis.
    Weiskopf RB
    Anesth Analg; 2012 Feb; 114(2):247-9. PubMed ID: 22266693
    [No Abstract]   [Full Text] [Related]  

  • 5. Theoretical modelling of fibrinogen supplementation with therapeutic plasma, cryoprecipitate, or fibrinogen concentrate.
    Collins PW; Solomon C; Sutor K; Crispin D; Hochleitner G; Rizoli S; Schöchl H; Schreiber M; Ranucci M
    Br J Anaesth; 2014 Oct; 113(4):585-95. PubMed ID: 25064078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haemostatic agents during laparoscopic nephron-sparing surgery: what about TachoSil?
    Falsaperla M; Autorino R; Puglisi M; Damiano R; Salerno GL; Motta M; Morgia G
    BJU Int; 2009 Jul; 104(2):270-1. PubMed ID: 19594516
    [No Abstract]   [Full Text] [Related]  

  • 7. Emotional or evidence-based medicine--is there a moral tragedy in haemostatic therapy?
    Kozek-Langenecker S; Sørensen B; Hess J; Spahn DR
    Crit Care; 2011; 15(6):462. PubMed ID: 22236360
    [No Abstract]   [Full Text] [Related]  

  • 8. Intraoperative hemostasis during kidney transplantation and the use collagen mesh dressing covered by fibrin glue (TachoComb).
    Pupka A; Chudoba P; Barć P; Kałuza G; Ruciński A; Janczak D; Pawłowski S; Szyber P
    Polim Med; 2003; 33(3):27-32. PubMed ID: 14696522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of mesh fibrous dressing covered with fibrin glue (TachoComb) in hemostasis after vascular anastomoses in the groin.
    Pupka A; Ruciński A; Pawłowski S; Barć P; Janczak D; Kałuza G; Szyber P
    Polim Med; 2004; 34(2):47-51. PubMed ID: 15497611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rational and timely haemostatic interventions following cardiac surgery - coagulation factor concentrates or blood bank products.
    Tang M; Fenger-Eriksen C; Wierup P; Greisen J; Ingerslev J; Hjortdal V; Sørensen B
    Thromb Res; 2017 Jun; 154():73-79. PubMed ID: 28437748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibrinogen in traumatic haemorrhage: A narrative review.
    Winearls J; Campbell D; Hurn C; Furyk J; Ryan G; Trout M; Walsham J; Holley A; Shuttleworth M; Dyer W; Keijzers G; Presneill J; Fraser JF; Wullschleger M
    Injury; 2017 Feb; 48(2):230-242. PubMed ID: 28088374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of TachoSil as haemostatic treatment versus standard suturing in kidney tumour resection: a randomised prospective study.
    Siemer S; Lahme S; Altziebler S; Machtens S; Strohmaier W; Wechsel HW; Goebell P; Schmeller N; Oberneder R; Stolzenburg JU; Becker H; Lüftenegger W; Tetens V; Van Poppel H
    Eur Urol; 2007 Oct; 52(4):1156-63. PubMed ID: 17467884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Editorial Comment on: Efficacy and safety of TachoSil as haemostatic treatment versus standard suturing in kidney tumour resection: a randomised prospective study.
    Sagalowsky AI
    Eur Urol; 2007 Oct; 52(4):1162-3. PubMed ID: 17467888
    [No Abstract]   [Full Text] [Related]  

  • 14. The place of fibrinogen concentrates in the management of perioperative bleeding: A position paper from the Francophone Working Group on Perioperative Haemostasis (GIHP).
    Samama CM; Ickx B; Ozier Y; Steib A; Susen S; Godier A
    Anaesth Crit Care Pain Med; 2018 Aug; 37(4):355-365. PubMed ID: 29660502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [TachoSil: the value of its use in urologic surgery. An interview with Professor Jacques Bisertes].
    Biserte J
    J Chir (Paris); 2007; 144(1):82-3. PubMed ID: 17385246
    [No Abstract]   [Full Text] [Related]  

  • 16. High-dose fibrinogen concentrate for haemostatic therapy of a major trauma patient with recent clopidogrel and aspirin intake.
    Schöchl H; Posch A; Hanke A; Voelckel W; Solomon C
    Scand J Clin Lab Invest; 2010 Oct; 70(6):453-7. PubMed ID: 20624109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibrinogen and hemostasis: a primary hemostatic target for the management of acquired bleeding.
    Levy JH; Szlam F; Tanaka KA; Sniecienski RM
    Anesth Analg; 2012 Feb; 114(2):261-74. PubMed ID: 21965371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma-derived biological medicines used to promote haemostasis.
    Ofosu FA; Freedman J; Semple JW
    Thromb Haemost; 2008 May; 99(5):851-62. PubMed ID: 18449414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant factor VIIa and other pro-haemostatic therapies in primary postpartum haemorrhage.
    Searle E; Pavord S; Alfirevic Z
    Best Pract Res Clin Obstet Gynaecol; 2008 Dec; 22(6):1075-88. PubMed ID: 18838340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Current perspective on the clinical use of fibrinogen].
    Yamazumi K; Kimura S; Okumura H; Aikou T; Ojiro M
    Rinsho Byori; 1997 Feb; Suppl 104():37-40. PubMed ID: 9128361
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.